50 A phase I study of the safety, tolerability and pharmacokinetics of pazopanib (P) in combination with gemcitabine (G) for advanced solid tumors

H. Richly; S.D. Rubin; A. Madi; M. Jeffels; B. Nokay; D. Gibson; S. Weller; M.E. Scheulen; R. Plummer

首页> 外文期刊>European Journal of Cancer Supplements >50 A phase I study of the safety, tolerability and pharmacokinetics of pazopanib (P) in combination with gemcitabine (G) for advanced solid tumors

【24h】

50 A phase I study of the safety, tolerability and pharmacokinetics of pazopanib (P) in combination with gemcitabine (G) for advanced solid tumors

机译：帕唑帕尼（P）与吉西他滨（G）联合用于晚期实体瘤的安全性，耐受性和药代动力学的50 A期I期研究

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2010年第7期|共页
作者
H. Richly; S.D. Rubin; A. Madi; M. Jeffels; B. Nokay; D. Gibson; S. Weller; M.E. Scheulen; R. Plummer;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 50 A phase I study of the safety, tolerability and pharmacokinetics of pazopanib (P) in combination with gemcitabine (G) for advanced solid tumors [J] . H. Richly, S.D. Rubin, A. Madi, European Journal of Cancer Supplements . 2010,第7期

机译：帕唑帕尼（P）与吉西他滨（G）联合用于晚期实体瘤的安全性，耐受性和药代动力学的50 A期I期研究
2. A Multicenter, Open-Label, Phase 1 Study Evaluating the Safety and Tolerability of Pegaspargase in Combination with Gemcitabine in Advanced Metastatic Solid Tumors and Lymphoma [J] . Borad Mitesh J., Babiker Hani M., Anthony Stephen, Cancer investigation . 2015,第Null期

机译：一项多中心，开放标签，第1期研究，评估Pegaspargase与吉西他滨联用在晚期转移性实体瘤和淋巴瘤中的安全性和耐受性
3. A Multicenter, Open-Label, Phase 1 Study Evaluating the Safety and Tolerability of Pegaspargase in Combination with Gemcitabine in Advanced Metastatic Solid Tumors and Lymphoma [J] . Borad Mitesh J., Babiker Hani M., Anthony Stephen, Cancer investigation . 2015,第Null期

机译：多中心，开放标签，第1期研究评估Pegaspargase与吉西他滨在先进的转移性实体肿瘤和淋巴瘤中组合的安全性和耐受性
4. Pharmacokinetics and Tolerability of Sublingual Fentanyl in Healthy Japanese and Caucasian Volunteers: Phase I, Open-Label Single-Dose Study [C] . U. Lorch, F. Farrell, J. Kilborn, International Pain Clinic Congress . 2008

机译：健康日本和白种人志愿者舌下芬太尼的药代动力学和耐受性：I期，开放标签单剂量研究
5. Brain tumor and nontumor tissue pharmacokinetics of gemcitabine: An in vivo assessment of the influence of the permeability modulators, irradiation and bradykinin agonist. [D] . Apparaju, Sandhya Kiran. 2003

机译：吉西他滨的脑肿瘤和非肿瘤组织药代动力学：体内对通透性调节剂，放射线和缓激肽激动剂影响的评估。
6. A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors [O] . Ruth Plummer, Ayman Madi, Melinda Jeffels, -1

机译：帕唑帕尼联合吉西他滨治疗晚期实体瘤的I期研究
7. A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors [O] . Ruth Plummer, Ayman Madi, Melinda Jeffels, 2012

机译：帕唑帕尼联合吉西他滨治疗晚期实体瘤的I期研究

50 A phase I study of the safety, tolerability and pharmacokinetics of pazopanib (P) in combination with gemcitabine (G) for advanced solid tumors

著录项

相似文献

相关主题

期刊订阅